Quick Takeaways
- Empery Asset Management, LP filed SCHEDULE 13G/A for Theriva Biologics, Inc. Common Stock, $0.001 par value per share (TOVX).
- Disclosed ownership: 5%.
- Date of event: 30 Sep 2025.
Empery Asset Management, LP - 30 Sep 2025 SCHEDULE 13G/A Report for Theriva Biologics, Inc. Common Stock, $0.001 par value per share (TOVX)
- Filing Manager
- Empery Asset Management, LP
- Reporting Manager
- Empery Asset Management, LP
- Symbol
- TOVX
- Shares outstanding
- 10,102,024 shares
- Disclosed Ownership
- 504,091 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 21 Oct 2025, 09:04:14 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 31 Jul 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Empery Asset Management, LP disclosed 5% ownership in Theriva Biologics, Inc. Common Stock, $0.001 par value per share (TOVX) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 31 Jul 2025.
- Current filing was accepted on 21 Oct 2025, 09:04.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Empery Asset Management, LP | 5% | 504,091 | 0 | 504,091 | /s/ Ryan M. Lane | By: Empery AM GP, LLC, its General Partner, By: Ryan M. Lane, its Managing Member | |
| Ryan M. Lane | 5% | 504,091 | 0 | 504,091 | /s/ Ryan M. Lane | Ryan M. Lane, individually | |
| Martin D. Hoe | 5% | 504,091 | 0 | 504,091 | /s/ Martin D. Hoe | Martin D. Hoe, individually |